C3a (source code)
= C3a
{c}
<C3a> is a small <protein> fragment released when <Complement C3> is cleaved during activation of the <complement system>. It is an <anaphylatoxin>, associated with inflammatory responses, and is distinct from the larger <C3b> product involved in surface-associated complement reactions. <Proteolysis> can thus produce different activities from different parts of one precursor.<Structures of complement component C3 provide insights into the function and evolution of immunity by Bert J. C. Janssen and others>[Introduction and Figure1: C3 activation and fragment organization]{ref}
In 1969, <Viktor A. Bokisch> and collaborators isolated <C3a> by several methods and tested its <smooth muscle>-contracting activity. Antiserum directed against <C3a> inhibited the biological response, connecting the isolated fragment to the activity rather than identifying it solely by a separation band. Further enzyme treatment changed its measured activities, showing why the amount of a fragment and its retained function are separate questions.<Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum by Viktor A. Bokisch and others>[Abstract: isolation, smooth-muscle response, antiserum inhibition and enzyme treatment]{ref}
An idealized bookkeeping example starts with 50 molecules of <Complement C3>, each undergoing exactly one activation cleavage. It produces 50 <C3a> fragments and 50 <C3b> fragments: 100 product molecules, but no doubling of total <protein> material. In an actual sample, production, further processing and removal all affect the measured concentration of <C3a>.
Back to article page